Literature DB >> 30729201

Genetic Changes in Pigeon Paramyxovirus Type-1 Induced by Serial Passages in Chickens and Microscopic Lesions Caused by the Virus in Various Avian Hosts.

Monika Olszewska-Tomczyk1, Izabella Dolka2, Edyta Świętoń1, Krzysztof Śmietanka1.   

Abstract

INTRODUCTION: Genotype VI of avian avulavirus 1 (AAvV-1) has pigeons and doves as its reservoir and is often termed pigeon paramyxovirus type-1 (PPMV-1). The pathogenesis of PPMV-1 infections in poultry is largely obscure. It is known that PPMV-1 requires a series of passages in chickens before it becomes adapted to gallinaceous poultry.
MATERIAL AND METHODS: Changes in the genome of PPMV-1 were analysed after serial passages in specific pathogen free (SPF) chickens, using high-throughput sequencing. Additionally, histopathological lesions induced by PPMV-1 in experimentally inoculated pigeons, chickens, and turkeys were evaluated.
RESULTS: Following six passages of PPMV-1 in chickens, 10 nonsynonymous substitutions were found including one (in the NP protein) which dominated the genetic pool of viral quasispecies. Histopathological changes induced by the post-passage PPMV-1 strain were more prominent than changes wrought by the pre-passaged PPMV-1 strain and the lesions were most intense in pigeons followed by chickens and turkeys.
CONCLUSION: PPMV-1 is highly adapted to pigeons and passaging through chickens results in the acquisition of novel amino acids in the polymerase complex, which may alter the pathogenic potential of the virus.

Entities:  

Keywords:  high-throughput sequencing; histopathological lesions; pigeon paramyxovirus type-1; pigeons; poultry

Year:  2018        PMID: 30729201      PMCID: PMC6364169          DOI: 10.2478/jvetres-2018-0059

Source DB:  PubMed          Journal:  J Vet Res        ISSN: 2450-7393            Impact factor:   1.744


Introduction

Avian avulavirus 1 (AAvV-1) is a species in the Paramyxoviridae family that encompasses different strains of avian paramyxoviruses type 1 (APMV-1) and affects wild and domestic avian hosts worldwide (1, 4, 9). The virus genome consists of a single molecule of single-stranded negative-sense RNA. Six structural proteins are encoded in the genome in the following order (3’-5’): nucleocapsid protein (NP), phosphoprotein (P), matrix protein (M), fusion protein (F), haemagglutinin-neuraminidase (HN), and polymerase (L). Additionally, nonstructural proteins V and W are generated via the RNA editing of the P gene (29). Similarly to other RNA viruses, AAvV-1 shows high variability, leading to generation of a diverse population of virus variants (quasispecies) which is an important factor affecting virus pathogenicity and adaptation properties (5, 23). Infections with AAvV-1 have a broad range of clinical manifestations, from asymptomatic through mild (with little or no mortality) to systemic (with moderate to high mortality) (1). The latter form, caused by virulent strains of AAvV-1, has been termed Newcastle disease (ND). The most important virulence marker is located in the F protein which is responsible for the fusion of the viral envelope with the endosomal membrane. F protein is produced as an inactive form F0 which needs cleavage into two subunits. The protein cleavage site of avirulent strains is monobasic and can be cleaved by trypsin-like proteases restricted to the respiratory and gastrointestinal tracts. In contrast, virulent strains have multiple basic amino acids at this motif which makes it susceptible to cleavage by ubiquitous host proteases resulting in systemic infections (12). However, the presence of a multibasic F cleavage site is not a definitive pathotype determinant and other genes also contribute to the virulence (26). There is a great genetic diversity among circulating AAvV-1 strains and based on the genetic characterisation of the fusion gene (F), two major genetic groups have been distinguished: class I and class II (9). Class I AAvV-1 strains are genetically homogenous and constitute a single genotype, mostly comprising strains of low virulence. The class II group is genetically very diverse and has been divided into 18 genotypes designated I to XVIII. The vast majority of class II AAvV-1 strains isolated from wild, feral and domestic pigeons have been classified to genotype VI and are frequently referred to as “pigeon paramyxovirus type 1” (PPMV-1). Since the late 1970s, there has been an ongoing panzootic in pigeons caused by PPMV-1 with occasional spillovers to poultry (9). In Europe, the disease in pigeons is widespread and has reached the status of endemicity (2). However, with the exception of rare epidemics of considerable magnitude in fowl (3), the incidence of reported PPMV-1 infections in poultry is relatively very low, considering the frequency of potential contacts between pigeons and poultry (2). The control of Newcastle disease in poultry does not take the genotype of AAvV-1 into account, but only the virulence of the strain that has caused infection (2, 8). Thus, the identification of virulent PPMV-1 in avian species that fall under the definition of “poultry” results in the notification of a Newcastle disease outbreak. Due to high adaptation to pigeons, natural infections with virulent PPMV-1 in fowl are often subclinical because the virulence criteria rely on the results of intracerebral inoculation of 1-day-old chicks, which is not the natural route of infection, or the assessment of molecular markers of virulence that do not always translate into pathogenicity in vivo (8, 24). In the current study, a detailed analysis of the genetic changes that occurred in the PPMV-1 as a result of serial passages in chickens were performed and pathological lesions induced by PPMV-1 in selected tissues of experimentally inoculated pigeons, chickens, and turkeys were assessed.

Material and Methods

Experimental design. The experimental setup was described previously (21). Briefly, the isolate PPMV-1/pigeon/Poland/332/05 was passaged six times in 3-week-old SPF chickens. First, three chickens were inoculated in the breast muscle with a dose of 107.3 EID50 of PPMV-1/pigeon/Poland/332/05 propagated in SPF embryonated eggs (332/05/0). On day 3 post infection (dpi) the birds were euthanised and spleens were collected and homogenised in PBS to obtain 20% w/v suspension. The homogenate was then centrifuged (15 min, 3,000 ×g) and the supernatant was used for inoculation of another group of SPF chickens. A total of six passages were performed in this way. Spleens of chickens from the 6th passage were prepared as described above and the obtained virus stock was designated 332/05/6. The viruses from the initial virus stock (332/05/0) and the post-passage virus (332/05/6) were used to inoculate ten 8-month-old pigeons, 3-week-old chickens, and 3-4-week-old turkeys via intraocular and intranasal routes with 106EID50 of each virus/bird. On the 4th, 7th, 10th, and 14th dpi in the case of pigeons, and on the 4th, 7th, and 10th dpi in the case of chickens and turkeys, two birds were euthanised and samples of the liver, kidney, duodenum, lung, pancreas, and brain were aseptically collected for histopathological examination. RT-PCR and Sanger sequencing. The viral RNA from allantoic fluid of 332/05/0 and spleen homogenate of 332/05/6 was extracted with a QIAamp Viral Mini Kit (Qiagen, Germany), according to the manufacturer’s protocol. The primers used in the RT-PCR were designed on the basis of sequences collected in the GenBank database (www.ncbi.nlm.nih.gov) and were all synthesised by Genomed (Poland). Sequences are presented in Table 1. The OneStep RT-PCR kit (Qiagen, Germany) was used according to the manufacturer’s instructions with the final primer concentration of 1 μM. With primer annealing temperature known to be around 55°C, the RT-PCRs were performed in the stages as follow: reverse transcription at 50°C for 30 min, denaturation at 95°C for 15 min, and 40 cycles of 95°C for 15 s, 55°C for 30 s, and 72°C for 1 min. The reaction was staged in a Veriti thermal cycler (Applied Biosystems, USA). The PCR products were purified with an ExoSAP-IT kit (Affymetrix, USA) and were sequenced using a BigDye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems, USA) in a 3500 genetic analyser (Applied Biosystems). Chromatograms were assembled with BioEdit software (version 7.2.5., Tom Hall of Ibis Therapeutics, USA) to obtain consensus sequences of 332/05/0 and 332/05/6. Molecular analysis comparing sequences of both strains was performed in MEGA6 software (32) and included all viral genes.
Table 1

Sequences of primers used for amplification and Sanger sequencing

PrimerSequence 5’-3’Location in the genomeProduct length (bp)
332-1FACCAAACAGAGAATCKGTGA1–20
332-1RGAATGTCTGATTGTGAGTTGAA771–792792
332-2FAGACAGCAGATGAGTCAGA672–690
332-2RGTTGCCCTTGCGACCTGC1,416–1,433762
332-3FTGGACATTCCCACTCAACA1,338–1,356
332-3RCCGACAGTCTCTGCTGATCTG1,976–1,996659
332-4FTTACCGATGCTGAGATAGAGG1,903–1,923
332-4RTCCAGAATTTTCATCATGCCTA2,719–2,740838
332-5FATGATGTCTATGATGGAGGCG2,571–2,591
332-5RGACGCTGGATCCTGTATTG3,413–3,431861
332-6FATCAATCTAACAGCATTAGAGA3,228–3,249
332-6RGTGACATTGAGCGCGAGA3,904–3,921694
332-7FGTGAAGGCACCTGAAAAGA3,764–3,782
332-7RGGTAAACTAACTATAAGCAATC4,460–4,481718
332-8FATAGAGAAGAGGCACACCA4,343–4,361
332-8RCCACTGCTAGCTGCGATAATC5,061–5,081739
332-9FGCCATTATAGGCAGTGTAG4,907–4,925
332-9RTTGCCGCTCAGACAAGAA5,629–5,646740
332-10FGGCTCTGTGATAGAAGAAC5,528–5,546
332-10RAGGGTGTTGTTCCCAAGCCACA6,159–6,180653
332-11FTGTCAAACTAACCAGCACATC6,025–6,045912
332-11RAGTGCAGCCTGATCCTGTA6,918–6,936
332-12FCAATAACATCTCTCTCTCATC6,734–6,754
332-12RCTCACCCAAAGATGTTGACAC7,549–7,569836
332-13FGTTGAAACCCAATTCGCCTA7,374–7,393
332-13RATCCTACATTCGACTCAAC8,151–8,169796
332-14FAGCATACACGACATCGACA7,989–8,007
332-14RCGTACCTCGTGTTGTGAATTTG8,738–8,759771
332-15FCTGCCACTCCTGATATTGA8,568–8,586
332-15RGCGTGAGTTACTGATTCCGC9,377–9,396829
332-16FGGCAATCAAGTCTATGATG9,221–9,239
332-16RTCTYAGGTACTCAAGGGTTG9,963–9,982762
332-17FAAGCAGGTGAAGGAGGCAAC9,869–9,888
332-17RGGAGTCATCTGATCTTACTTC10,664–10,684816
332-18FTGCCAGAAGCTATGGACAATG10,547–10,567
332-18RGGCTTGCAACAGTCTCAA11,328–11,345799
332-19FCAGAGGTCAAGCGATTAG11,205–11,222
332-19RCCCAGATTAACACGGACGATG12,048–12,068864
332-20FGAGCTGACTGACGATACCA11,915–11,933
332-20RCTGGGCTTCACTAATCCAA12,736–12,754840
332-21FAAGACTATTTACTGAAGAAGGAA12,280–12,302
332-21RTCTGCAAGCTGGTGTGAC12,982–12,999720
332-22FAGTGAGAGGTCTCAACAACA12,835–12,854
332-22RGCAGTCCCTATTCCTCTGAA13,616–13,635801
332-23FAACCTGCATCATTCATACAAGAA13,488–13,510
332-23RTTTGCCATCCTCACTACT14,302–14,319832
332-24FGTGGAGTAGTGATCATCAAAG14,118–14,138
332-24RGGAGTAAACAAGAACACTGTG14,632–14,652535
332-25FCAGAGAGTTTRGTGRGCACA14,514–14,533
332-25RAAACAAAGATTTGGTGAATGACAA15,166–15,189676
Sequences of primers used for amplification and Sanger sequencing Deep sequencing and bioinformatic analysis. For deep sequencing, the RNAs from both virus stocks were extracted with a NucleoSpin NA Plus kit (Macherey-Nagel, Germany), including a step of genomic DNA removal. Separate templates were prepared for viruses 332/05/0 and 332/05/6. Prepared libraries were sequenced with SBS (sequencing by synthesis) conducted in MiSeq in mode PE250 (Illumina, USA). Library preparation and sequencing was performed by Genomed. The quality of raw reads was examined in FastQC software (www.bioinformatics.babraham.ac.uk/projects/fastqc/) The reads were trimmed in Trimmomatic (The Usadel Lab, Germany) to remove low quality data and adapter sequences (7) and then were assembled in the Burrows–Wheeler alignment tool (BWA) (http://biobwa.sourceforge.net) (20) with the consensus sequence of 332/05/0 as a reference. BAM files were processed in Samtools (www.htslib.org) to obtain mpileup files used as an input for variant calling in VarScan (http://varscan.sourceforge.net) (18). To minimise the probability of false positive calls resulting from sequencing errors, only variants with a frequency of >1% in positions with a coverage of ≥500× were considered. All variants were inspected visually in the alignment in Tablet software (https://ics.hutton.ac.uk) (25). Histopathology. Tissue samples were fixed in 10% buffered formalin, processed, and paraffin embedded. Paraffin blocks were cut into 6 μm sections, and then stained with haematoxylin and eosin (HE). Each tissue sample was evaluated for the presence of elementary histopathological lesions, e.g., cellular infiltration (mononuclear or mixed), necrosis, degeneration, congestion, haemorrhages, and other lesions specific for the organ/tissue (e.g hepatic macrophages hyperplasia, gliosis, or BALT hyperplasia) in 10 randomly selected fields for each case at magnification 10× and 40×. Grading of lesions was carried out on a descriptive scale as follows: none, scant, mild, moderate, and severe.

Results

Molecular analysis of non-passaged and passaged isolate. Comparison of consensus sequences of 332/05/0 and 332/05/6 viruses revealed one nonsynonymous mutation located in position 1,550 in the NP gene. This change resulted in substitution of histidine with asparagine in position 477 of the NP protein. However, deep sequencing revealed the presence of minority variants in both 332/05/0 and 332/05/6 virus populations. Five low frequency variants were identified in 332/05/0, all located in the L gene. One of them, present with frequency of 7.34%, was a nonsynonymous mutation causing change of methionine to valine at position 1,674 of the L protein. Higher complexity was revealed in the viral population of the passaged isolate. Twenty-nine variant positions were identified in the coding regions and seven in the non-coding regions (Table 2). Ten mutations entailed change in amino acid sequence. In the NP protein, two variants with nonsynonymous mutations were detected. One of them was located at position 1,550 with frequency of ~80%, which was in agreement with the analysis of consensus sequences from Sanger sequencing. Three nonsynonymous mutations were detected in the P protein with variants at positions 2,154 and 2,407 present at a relatively high frequency. One and two low frequency amino acid substitutions were detected in the M and HN proteins, respectively. Two nonsynonymous mutations were also identified in the L gene (Table 2). None of the minority variants detected in the non-passaged isolate was maintained in the passaged isolate.
Table 2

Location and frequency of variants in the virus population of post-passage 332/05 (332/05/06) in reference to the consensus sequence of non-passaged virus stock (332/05/0)

Nucleotide positionNucleotide in consensus sequence of 332/05/0Nucleotide variant in 332/05/6Variant frequency (%)Amino acid change 332/05/0→332/05/6Protein
1,503CT2.28A461VNP
1,550CA80.75H477N
1,576CA5.36none
1,829TC1.34non-coding
1,856CT5.81non-coding
2,072CT2.6noneP
2,154CT17.68P88S
2,407CT20.97P172L
2,718TC4.77none
2,846AG6.4none
3,014TA1.26S374R
3,337CT13.64noneM
3,927AG1.39D211G
4,141GT1.28none
4,494TA2.23non-coding
5,755AG1.73noneF
6,371GT3.76non-coding
6,517AG2.27M34VHN
6,693TC5.55none
7,404AG2.86none
7,649AC1.12H411P
7,728TG11.21none
8,175GA2.39non-coding
8,267AG1.42non-coding
9,274TC1.76noneL
9,671CA1.01H429N
10,126CT1.31none
10,411TC1.81none
11,059GA2.1none
13,417CT2.16none
13,463CA1.26none
13,690TC1.7none
13,896AG2.06K1837R
14,173CT1.71none
14,929TC1.89none
15,094TA16.58non-coding
Location and frequency of variants in the virus population of post-passage 332/05 (332/05/06) in reference to the consensus sequence of non-passaged virus stock (332/05/0) Histopathological findings. The intensity of lesions was the highest in pigeons, with chickens next and turkeys with the least intense changes. Generally, the observed histopathological lesions were mild but more pronounced in birds infected with the passaged PPMV-1. Histopathological findings in pigeons In the brain, multifocal mild perivascular mononuclear cell infiltration was noted on the 14th dpi (Fig. 1A) At the same time focal perivascular infiltration of mononuclear cells affecting the meninges was observed. Multifocal gliosis with formation of nodules, mild neuronal degeneration, endothelial hypertrophy, oedema and congestion were also found. In the liver, multifocal, mild to moderate infiltration of mononuclear cells (mainly lymphocytes, plasma cells) and heterophils was observed in all groups of birds. Cellular infiltrates were found in portal triads, perivascular region, and in the subcapsular area. Heterophil infiltration was less prominent on the 14th dpi than in the contact case (14 dpi_K). Although proliferation of Kupffer cells (hepatic macrophages) and hepatocyte lipid accumulation were observed in many sections, they were more prominent on the 10th and 7 th dpi, respectively. Additionally, the presence of haemosiderin-laden macrophages was noted. Changes such as necrosis of hepatocytes of the periportal zone and biliary epithelial cell proliferation were present in one case (14 dpi). A predominant histological finding in the kidneys was diffuse marked interstitial nephritis (lymphoplasmacytic heterophilic), sometimes associated with tubular necrosis (10 dpi, 14 dpi, 14 dpi_K, Fig. 1D) Occasionally, renal tubules were mildly dilated and filled with eosinophilic crystalline deposits. Additionally, the renal medulla was affected on the 14th dpi and 14th dpi_K. Moderate diffuse mononuclear cell infiltration and lymphoid aggregation (gut-associated lymphoid tissue (GALT) hyperplasia) were found in the duodenal mucosa on the 10th and 14th dpi. Marked multifocal lymphocytic pancreatitis was noted on the 14th dpi when conspicuous to moderate multifocal necrosis of the pancreatic acinar cells was also observed as it also was on the 14th dpi_K. In the lungs, the presence of lymphoid aggregates in the bronchial mucosa (bronchus-associated lymphoid tissue (BALT) hyperplasia) and within interstitial tissue was common on the 10th and 14th dpi (Fig. 1G). Surprisingly, a single granulomatous lesion with central necrosis surrounded by multinucleated giant cells was found in two cases (4 and 10 dpi).
Fig. 1

Representative images of the brain (A–C), kidney (D–F), and lung (G–I) from pigeons (A, D, G), chickens (B, E, H), and turkeys (C, F, I) comparing the severity of diagnosed lesions between groups

Brain: mononuclear inflammatory infiltrates in perivascular spaces and gliosis were more marked in pigeons (A) than chickens (B). Turkeys demonstrated no encephalitis (C). An insert in the right corner of Fig. 1A shows a glial nodule, and focal lymphoplasmacytic meningitis Kidney: in pigeons there were severe diffuse interstitial nephritis composed primarily of mononuclear cells and a smaller number of heterophils, with tubular necrosis (D). An insert image in the upper right corner of Fig. 1D shows eosinophilic crystalline deposits filling tubular lumens. In chickens multifocal infiltration of mononuclear cells and focal tubular degeneration or necrosis (E) were seen, whereas in turkeys scanty focal interstitial nephritis (arrow) and haemorrhages were shown (F)

Lung: multifocal lymphoid aggregates (arrows) scattered throughout the interstitial pulmonary tissue in pigeons (G); BALT hyperplasia was observed among all birds (arrows, insert images 1G and 1I; and Fig.1H). However, in chickens and turkeys this finding was the only one that was a more notable pulmonary change

HE. Scale bar indicates 20 μm (A–C), 50 μm (D–F), 200 μm (G–I)

Representative images of the brain (A–C), kidney (D–F), and lung (G–I) from pigeons (A, D, G), chickens (B, E, H), and turkeys (C, F, I) comparing the severity of diagnosed lesions between groups Brain: mononuclear inflammatory infiltrates in perivascular spaces and gliosis were more marked in pigeons (A) than chickens (B). Turkeys demonstrated no encephalitis (C). An insert in the right corner of Fig. 1A shows a glial nodule, and focal lymphoplasmacytic meningitis Kidney: in pigeons there were severe diffuse interstitial nephritis composed primarily of mononuclear cells and a smaller number of heterophils, with tubular necrosis (D). An insert image in the upper right corner of Fig. 1D shows eosinophilic crystalline deposits filling tubular lumens. In chickens multifocal infiltration of mononuclear cells and focal tubular degeneration or necrosis (E) were seen, whereas in turkeys scanty focal interstitial nephritis (arrow) and haemorrhages were shown (F) Lung: multifocal lymphoid aggregates (arrows) scattered throughout the interstitial pulmonary tissue in pigeons (G); BALT hyperplasia was observed among all birds (arrows, insert images 1G and 1I; and Fig.1H). However, in chickens and turkeys this finding was the only one that was a more notable pulmonary change HE. Scale bar indicates 20 μm (A–C), 50 μm (D–F), 200 μm (G–I) Histopathological findings in chickens. The brain showed occasional scant perivascular mononuclear cell infiltration on the 4th and 7th dpi (Fig. 1 B) Some vessels indicated a slight endothelial hypertrophy. A mild increased glial hyperplasia and neuronal degeneration were frequently noted on the 7th dpi. In the liver, multifocal moderate mononuclear cell infiltration, occasionally mixed with heterophils, and marked Kupffer cell hyperplasia was noted on the 7th dpi. These findings were present on the 4th dpi, but less intense than on the 7th dpi. Lipid deposition in hepatocytes and periportal mild fibrosis were also observed. In the kidney on the 7th dpi, there were multifocal mononuclear infiltrates associated with tubule necrosis (Fig. 1E) The kidney from both cases also revealed mild tubular degeneration and congestion. Diffuse mononuclear cell infiltration, mild GALT hyperplasia, and congestion were slightly more evident in the duodenal mucosa on the 7th dpi. Enterocyte proliferation was higher on the 4th dpi than on the 7th dpi. In the pancreas, there was a sparse mononuclear cell infiltrate, however, on the 7th dpi more advanced lesions developed. An infiltration of mononuclear cells was followed by necrotic foci of the pancreatic acinar cells (7 dpi). In the lungs, only focal lymphoid aggregates of the bronchial mucosa were observed on the 4th and 7th dpi (Fig. 1 H) Histopathological findings in turkeys. In the brain, occasional neuronal degeneration, slight glial cell hyperplasia and congestion were observed. In the liver, the presence of inextensive focal mononuclear cell infiltration significantly distinguished the 7th dpi samples from others. Marked diffuse hepatocellular lipid accumulation occurred on the 10th dpi. Scant interstitial focal nephritis was observed on dpi 4 and 7, with mild focal haemorrhages on the 4th dpi (Fig. 1F) The duodenal mucosa showed mild diffuse mononuclear cell infiltration, occasionally with scant focal GALT hyperplasia (10 dpi). In the kidney, scant focal interstitial nephritis was observed on dpi 4 and 7, with mild focal haemorrhages on dpi 4. The pancreas revealed small foci of mononuclear cells (10 dpi) and vacuolation of single acinar cells. In the lungs and brain, there were no differences between cases. In the lungs, slight focal BALT hyperplasia and mild marginal emphysema were noted (Fig. 1H)

Discussion

In the previous study (31), we investigated the clinical course, virus distribution, replication, and transmission of PPMV-1 in various species of birds and found that only pigeons succumbed to the infection, while chickens, turkeys, geese, and quail remained healthy. The virus showed different levels of replication and shedding. It was shown that PPMV-1 requires a series of passages in chickens in order to regain adaptation and pathogenic potential in Galliformes (11), so to increase the level of PPMV-1 adaptation to gallinaceous poultry, serial passages of the native PPMV-1 strain in chickens were performed. Despite a slight increase in virulence (as measured by the intracerebral pathogenicity index value, ICPI) no noticeable difference in terms of clinical manifestation between non-passaged and passaged PPMV-1 was observed. The present study is a follow-up investigation in which we analysed the distribution of viral quasispecies in the virus stock obtained from the original PPMV-1 isolate and the same strain passaged several times in SPF chickens. Additionally, it describes microscopic lesions induced by both strains in pigeons and two representatives of gallinaceous birds: chickens and turkeys. The Sanger sequencing of 332/05/0 and 332/05/6 revealed one nonsynonymous mutation (H477N) in the consensus sequence of NP. However, previous studies showed that the composition of NDV viral quasispecies is an important factor contributing to the virulence (5, 16, 23), therefore we decided to deepen the analysis to the level of viral subpopulations of the non-passaged and passaged virus stocks. The high-throughput sequence analysis of the quasispecies populations in the non-passaged PPMV-1 revealed only one minor variant with nonsynonymous mutation. In contrast, in the passaged PPMV-1 ten nonsynonymous mutations were identified with only one dominant substitution (H477N) in the NP protein (~80% frequency), which corroborated the results of Sanger sequencing. There was no variation at this position in the non-passaged isolate, which suggests that this mutation emerged during passages. Two nonsynonymous minority variants in the P protein occurred with a noticeable frequency of ~17% to ~20%. The frequency of the remaining substitutions was very low (approx. 1%– 2%). Therefore, the quasispecies distribution in passaged PPMV-1 was slightly but unequivocally different (both genetically and phenotypically), from the original virus population in non-passaged PPMV-1. None of the low-frequency variants present in the non-passaged virus stock was detected in the passaged virus, and vice versa It suggests that the selection pressure of the new host (chicken) sparked phenotypic alterations in the tested PPMV-1 and the emergence of a distinct mutant spectrum in the passaged isolate can explain the observed changes in ICPI values obtained in the previous paper (31). The observed substitutions are located in the NP/P/L proteins that together form the replication complex of the virus. Previous experiments showed an increase in the virulence of PPMV-1 as a result of passages in chickens. No mutations in the F protein were observed in that study, but augmented virulence was caused by mutations in the polymerase complex proteins (11). The presence of a polybasic cleavage site of the F protein does not always correlate with the pathogenicity (10), which was also demonstrated for avian paramyxovirus 2 (APMV-2) (30). The observed changes at the molecular level can explain differences in the intensity of histopathological lesions that were more pronounced in tissues collected from birds infected with the passaged PPMV-1. The NP encapsidates the viral RNA, and thus it participates in the regulation of replication, transcription and virus assembly. The mutation H477N in the NP is located in the C-terminal region, within a domain that probably has high functional and structural significance (residues 442–489) (22), including interaction with the P protein and RNA synthesis (17 33), therefore it might affect the efficiency of virus replication. A previous study showed that mutation NP-E402A caused enhanced synthesis of viral RNA in a cell culture at the beginning of infection but that it decreased later on which resulted in reduced replication of the virus from 36 hours post infection compared to the wild-type strain possessing NP-E402 (33). A higher level of viral RNA entailed increased efficiency of virus production leading to faster death of infected cells, which restrained the virus replication at the later stages of infection. The mutated virus also showed higher virulence for 1-day-old chicks as evidenced by a higher value of ICPI when lower virus doses were used (33). Similarly, mutation H477N might also contribute to an increased ICPI value of the passaged PPMV-1 and enhance the virus replication in the tested species. This might also be the reason for more pronounced lesions in organs from birds infected with the passaged virus. The correlation between the virus load, innate immune response, and intensity of histopathological lesions has been observed in another study (13). Nevertheless, the role of NP-H477N mutation in the alteration of virus virulence and its effect on the microscopic lesions needs further investigation. As regards the examined species, the lesions were most prominent in pigeons followed by chickens and turkeys. The striking difference in the extent and intensity of lesions between pigeons and Galliformes is explained by the existence of host-specific adaptive features which have been only partially identified at molecular level (11). PPMV-1 is highly adapted to pigeons and lesions caused by the virus in tissues of its natural host are systemic and occasionally quite extensive. Some of the lesions found in our study were consistent with those described in previous reports, for example: perivascular lymphocytic cuffings and gliosis in the brain, nephritis and tubular necrosis in the kidneys, lymphocytic pancreatitis, and pulmonary congestion (6, 15 27). It was shown previously that PPMV-1 is neuro- and nephrotropic (14, 21 28) and our findings corroborate these observations. Descriptions of microscopic lesions caused by PPMV-1 in chickens are scarce. The microscopic lesions found in our study were mild but involved multiple organs. Kommers et al. (19) reported that the most remarkable findings in chickens had been observed in the brain and included mononuclear inflammatory infiltrations, perivascular cuffs, endothelial cell hyperplasia, chromatolysis in the cerebral neurons, areas of gliosis, Purkinje cell necrosis, and vacuolisation in the cerebellar white matter. Although not all birds with lesions in the brain suffered from neurological conditions, the authors concluded that PPMV-1 is neurotropic in chickens. In our study, neurological signs were not observed, and lesions detected in the brain were mild and scant. This discrepancy can be explained by the age differences of birds used in the studies and/or variations in the individual pathogenic properties of the PPMV-1 strains used for inoculation in various experiments. To the best of our knowledge, histologic lesions induced by PPMV-1 in turkeys have not been described so far. In the present study, we found mild to moderate inflammatory lesions (focal or diffuse infiltration of cells) in the liver, kidneys, duodenum and pancreas as well as slight glial hyperplasia and neuronal degeneration. The combined clinical and pathological data obtained for chickens and turkeys clearly indicate that passaging of pigeon-derived PPMV-1 isolates in chickens does not always occasion a significant alteration of the pathogenic properties following inoculation by natural routes (respiratory/digestive), although, as mentioned above, a qualitative assessment of histological findings indicated more pronounced microscopic lesions in tissues collected from birds infected with the passaged PPMV-1. The results obtained in our study warrant further investigations on the role of specific mutations produced in the polymerase complex of the virus as a result of passaging in gallinaceous birds, especially in the context of tissue tropism and intensity of lesions.
  32 in total

1.  Avian paramyxovirus type 1 infections in racing pigeons in California. I. Clinical signs, pathology, and serology.

Authors:  J T Barton; A A Bickford; G L Cooper; B R Charlton; C J Cardona
Journal:  Avian Dis       Date:  1992 Apr-Jun       Impact factor: 1.577

2.  Quasispecies nature of an unusual avian paramyxovirus type-1 isolated from pigeons.

Authors:  Cyril Barbezange; Véronique Jestin
Journal:  Virus Genes       Date:  2005-05       Impact factor: 2.332

Review 3.  Viral infections in pigeons.

Authors:  D Marlier; H Vindevogel
Journal:  Vet J       Date:  2006-07       Impact factor: 2.688

4.  Evolution of pigeon Newcastle disease virus strains.

Authors:  G Meulemans; T P van den Berg; M Decaesstecker; M Boschmans
Journal:  Avian Pathol       Date:  2002-10       Impact factor: 3.378

5.  Pathogenesis of six pigeon-origin isolates of Newcastle disease virus for domestic chickens.

Authors:  G D Kommers; D J King; B S Seal; K P Carmichael; C C Brown
Journal:  Vet Pathol       Date:  2002-05       Impact factor: 2.221

6.  Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope.

Authors:  Teshome Mebatsion; Marck J M Koolen; Leonie T C de Vaan; Niels de Haas; Marian Braber; Angela Römer-Oberdörfer; Paul van den Elzen; Pieter van der Marel
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Tablet--next generation sequence assembly visualization.

Authors:  Iain Milne; Micha Bayer; Linda Cardle; Paul Shaw; Gordon Stephen; Frank Wright; David Marshall
Journal:  Bioinformatics       Date:  2009-12-04       Impact factor: 6.937

8.  Regions on nucleocapsid protein of Newcastle disease virus that interact with its phosphoprotein.

Authors:  C L Kho; W S Tan; B T Tey; K Yusoff
Journal:  Arch Virol       Date:  2004-01-29       Impact factor: 2.574

9.  Analysis of Newcastle disease virus quasispecies and factors affecting the emergence of virulent virus.

Authors:  Jacqueline A Kattenbelt; Matthew P Stevens; Paul W Selleck; Allan R Gould
Journal:  Arch Virol       Date:  2010-07-03       Impact factor: 2.574

10.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

View more
  3 in total

1.  Broad and Dynamic Diversification of Infectious Hepatitis C Virus in a Cell Culture Environment.

Authors:  Isabel Gallego; María Eugenia Soria; Carlos García-Crespo; Qian Chen; Patricia Martínez-Barragán; Soumaya Khalfaoui; Brenda Martínez-González; Irene Sanchez-Martin; Inés Palacios-Blanco; Ana Isabel de Ávila; Damir García-Cehic; Juan Ignacio Esteban; Jordi Gómez; Carlos Briones; Josep Gregori; Josep Quer; Celia Perales; Esteban Domingo
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

2.  Innate immune responses of domestic pigeons to the infection of pigeon paramyxovirus type 1 virus.

Authors:  Fangfang Wang; Mengying Gao; Zongxi Han; Yutong Hou; Lili Zhang; Zhanbang Ma; Deying Ma
Journal:  Poult Sci       Date:  2020-11-28       Impact factor: 3.352

Review 3.  Occurrence and Role of Selected RNA-Viruses as Potential Causative Agents of Watery Droppings in Pigeons.

Authors:  Ewa Łukaszuk; Tomasz Stenzel
Journal:  Pathogens       Date:  2020-12-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.